|
| 产品描述 |
| Recilisib, also known as ON 01210.Na, is a radioprotectant, which modifys cell cycle distribution patterns in cancer cells subjected to radiation therapy, and it has been identified as a potential candidate for radiation protection studies. It appears that Recilisib radioprotective mechanisms involve prevention of p53-dependent and independent radiation-induced apoptosis. |
| 化学结构 |
 |
| 化学名称 |
| sodium (E)-4-(2-((4-chlorobenzyl)sulfonyl)vinyl)benzoate |
| SMILES Code |
| O=C([O-])C1=CC=C(/C=C/S(=O)(CC2=CC=C(Cl)C=C2)=O)C=C1.[Na+] |
| 基本信息 |
产品编号:XM151
产品名称:Recilisib sodium
别名:Recilisib; ON 01210.Na; ON-01210; ON01210; ON01210; Brand name: Ex-RAD
CAS#:334969-03-8 (sodium)
分子式:C16H12ClNaO4S
分子量:358.7678
|
| 物化性质 |
外观: 白色固体粉末
纯度: >98%
运输信息: 非危险化学品，适于常温或冰袋运输。
储存条件: 低温，干燥，避光。
溶解性: 溶于DMSO, 不溶于水
储存期限:3年 -20℃固体储存
2 年 -80℃ 溶液储存 |
该产品只供科研使用，不能给病人提供。
|
|
|
